KNSA logo

Kiniksa Pharmaceuticals (KNSA) Company Overview

Profile

Full Name:

Kiniksa Pharmaceuticals International, plc

Sector:

Healthcare

Country:

United Kingdom

IPO:

May 25, 2018

Indexes:

Not included

Description:

Kiniksa Pharmaceuticals (KNSA) is a biopharmaceutical company focused on developing and commercializing innovative therapies for patients with serious diseases. They aim to address unmet medical needs through research and development of new treatments, particularly in immunology and rare diseases.

Key Details

Price

$21.46

Annual Revenue

$423.24 M(+56.60% YoY)

Annual EPS

-$0.60(-400.00% YoY)

Beta

0.93

Events Calendar

Earnings

Next earnings date:

Apr 23, 2025

Recent quarterly earnings:

Feb 25, 2025

Recent annual earnings:

Feb 25, 2025
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Nov 5, 24 JP Morgan
Overweight
Oct 30, 24 Evercore ISI Group
Outperform
Jul 23, 24 Wedbush
Outperform
May 3, 24 Wells Fargo
Overweight
May 1, 24 JP Morgan
Overweight
Apr 24, 24 Evercore ISI Group
Outperform
Jan 2, 24 Wedbush
Outperform
Jul 26, 23 Goldman Sachs
Buy
Mar 9, 23 JP Morgan
Overweight
Dec 29, 21 B of A Securities
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Kiniksa Pharmaceuticals?
  • Does Kiniksa Pharmaceuticals pay dividends?
  • What sector is Kiniksa Pharmaceuticals in?
  • What industry is Kiniksa Pharmaceuticals in?
  • What country is Kiniksa Pharmaceuticals based in?
  • When did Kiniksa Pharmaceuticals go public?
  • Is Kiniksa Pharmaceuticals in the S&P 500?
  • Is Kiniksa Pharmaceuticals in the NASDAQ 100?
  • Is Kiniksa Pharmaceuticals in the Dow Jones?
  • When was Kiniksa Pharmaceuticals's last earnings report?
  • When does Kiniksa Pharmaceuticals report earnings?
  • Should I buy Kiniksa Pharmaceuticals stock now?

What is the ticker symbol for Kiniksa Pharmaceuticals?

The ticker symbol for Kiniksa Pharmaceuticals is NASDAQ:KNSA

Does Kiniksa Pharmaceuticals pay dividends?

No, Kiniksa Pharmaceuticals does not pay dividends

What sector is Kiniksa Pharmaceuticals in?

Kiniksa Pharmaceuticals is in the Healthcare sector

What industry is Kiniksa Pharmaceuticals in?

Kiniksa Pharmaceuticals is in the Drug Manufacturers - Specialty & Generic industry

What country is Kiniksa Pharmaceuticals based in?

Kiniksa Pharmaceuticals is headquartered in United Kingdom

When did Kiniksa Pharmaceuticals go public?

Kiniksa Pharmaceuticals's initial public offering (IPO) was on May 25, 2018

Is Kiniksa Pharmaceuticals in the S&P 500?

No, Kiniksa Pharmaceuticals is not included in the S&P 500 index

Is Kiniksa Pharmaceuticals in the NASDAQ 100?

No, Kiniksa Pharmaceuticals is not included in the NASDAQ 100 index

Is Kiniksa Pharmaceuticals in the Dow Jones?

No, Kiniksa Pharmaceuticals is not included in the Dow Jones index

When was Kiniksa Pharmaceuticals's last earnings report?

Kiniksa Pharmaceuticals's most recent earnings report was on Feb 25, 2025

When does Kiniksa Pharmaceuticals report earnings?

The next expected earnings date for Kiniksa Pharmaceuticals is Apr 23, 2025

Should I buy Kiniksa Pharmaceuticals stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions